Novo Nordisk A/S (NVO) Options Chain & Prices $51.06 +2.30 (+4.72%) Closing price 08/8/2025 03:59 PM EasternExtended Trading$51.18 +0.12 (+0.24%) As of 08/8/2025 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVO Put and Call Options List 12/17/2027 1/15/2027 9/18/2026 6/18/2026 3/20/2026 1/16/2026 12/19/2025 11/21/2025 10/17/2025 9/26/2025 9/19/2025 9/12/2025 9/5/2025 8/29/2025 8/22/2025 8/15/2025 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export to Excel ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades8/15/2025$41.00$0.018Put2 - 166(+1)70.18% (+9.15%)-0.01099728/15/2025$42.00$0.022Put1413 - 1294(-11)64.84% (+8.86%)-0.0137748/15/2025$42.50$0.024Put1913 - 396(+6)62.25% (+8.71%)-0.015589158/15/2025$43.00$0.027Put7726297(+0)59.74% (+8.29%)-0.017823108/15/2025$43.50$0.030Put71463(-16)57.31% (+7.69%)-0.0206278/15/2025$44.00$0.035Put10747810939(+9799)55.00% (+6.92%)-0.024173218/15/2025$44.00$7.067Call6 - - 26(-30)55.00% (+6.74%)0.97585328/15/2025$44.50$0.041Put1152777407(+264)52.79% (+6.00%)-0.028747138/15/2025$44.50$6.574Call1 - - 73(-5)52.79% (+6.00%)0.97129118/15/2025$45.00$0.049Put67628521810692(-134)50.72% (+4.94%)-0.034712135 Get the Latest News and Ratings for NVO and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Novo Nordisk A/S and its competitors with MarketBeat's FREE daily newsletter. 8/15/2025$45.00$6.082Call1423379432(-102)50.72% (+4.94%)0.965352298/15/2025$45.50$0.060Put1845255(-2)48.79% (+3.79%)-0.042553148/15/2025$45.50$5.593Call55 - 51288(-27)48.79% (+3.61%)0.95753768/15/2025$46.00$0.074Put476193771162(+50)47.01% (+2.59%)-0.052939608/15/2025$46.00$5.108Call39632167636(-130)47.01% (+2.59%)0.947197378/15/2025$46.50$0.094Put42424254(+212)45.41% (+1.40%)-0.066748258/15/2025$46.50$4.628Call1537775225(-57)45.41% (+1.40%)0.933458198/15/2025$47.00$0.122Put425187881727(+655)44.00% (+0.23%)-0.08504838/15/2025$47.00$4.156Call11329731326(-131)44.00% (+0.07%)0.915245348/15/2025$47.50$0.160Put1331860630(+504)42.78% (-0.86%)-0.109073418/15/2025$47.50$3.695Call28111250388(-88)42.78% (-0.86%)0.891333318/15/2025$48.00$0.213Put6583661801633(+865)41.76% (-1.87%)-0.1401351358/15/2025$48.00$3.248Call9005542321973(+511)41.76% (-1.87%)0.8604571838/15/2025$48.50$0.285Put52654445109(+67)40.94% (-2.78%)-0.179265688/15/2025$48.50$2.820Call235132902084(+172)40.94% (-2.94%)0.821573678/15/2025$49.00$0.382Put4951921381138(+53)40.31% (-3.75%)-0.2270381618/15/2025$49.00$2.417Call395622103242(+2318)40.31% (-3.60%)0.7741121038/15/2025$49.50$0.507Put54236093426(+26)39.86% (-4.32%)-0.2832211128/15/2025$49.50$2.042Call1468426234(+114)39.86% (-4.32%)0.718313468/15/2025$51.00$1.101Put804393274134(+9)39.48% (-6.06%)-0.4864831458/15/2025$51.00$1.133Call1,4035344537150(+3956)39.48% (-5.52%)0.516533598/15/2025$52.00$1.692Put1961523207(+5)39.96% (-7.00%)-0.624389658/15/2025$52.00$0.722Call2,5791,0908671177(+51)39.79% (-7.35%)0.3796764388/15/2025$53.00$2.423Put13046266(+3)41.00% (-7.88%)-0.740518138/15/2025$53.00$0.449Call1,774233927937(+22)41.00% (-7.88%)0.2643982368/15/2025$54.00$3.260Put4842 - 15(+10)42.65% (-8.71%)-0.826078128/15/2025$54.00$0.282Call1,7121,1592173192(+174)42.65% (-8.71%)0.1794641938/15/2025$55.00$4.166Put8910454286(-213)44.93% (-9.46%)-0.882769318/15/2025$55.00$0.185Call1,5585024894275(-105)44.78% (-9.61%)0.122882868/15/2025$56.00$5.114Put61601121(+0)47.84% (-10.03%)-0.9180467Buffett’s $325 Billion Cash Problem — Solved by Gold? (Ad)A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most investors are still asleep… but not for long. Garrett Goggin’s latest research reveals how you can “front-run” the greatest investor alive by positioning in four small miners sitting on up to 100X potential upside. When this hits the news — it’ll be too late.Discover how you could front-run Buffett’s gold move with Garrett’s Top Four picks.8/15/2025$56.00$0.130Call917261375876(+144)47.84% (-10.03%)0.087472898/15/2025$57.00$6.086Put4 - - 410(+2)51.32% (-10.33%)-0.93937318/15/2025$57.00$0.099Call1133317447(+11)49.85% (-12.05%)0.065843378/15/2025$58.00$0.081Call51129594(+7)55.24% (-10.58%)0.05247178/15/2025$59.00$8.061Put221012249(+1)59.45% (-10.07%)-0.96059158/15/2025$59.00$0.071Call22181666(-4)59.45% (-10.32%)0.04386388/15/2025$60.00$9.055Put474193644(-145)63.79% (-9.64%)-0.96616248/15/2025$60.00$0.064Call461374063873(+149)63.79% (-9.64%)0.037972778/15/2025$61.00$0.060Call5 - 5163(-3)68.15% (-9.11%)0.0336543End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies Novartis Options AstraZeneca Options Sanofi Options GSK Options Takeda Pharmaceutical Options argenex Options BioNTech Options Summit Therapeutics Options Insmed Options Teva Pharmaceutical Industries Options Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NYSE:NVO) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novo Nordisk A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Novo Nordisk A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVO Stock Alerts